Using a novel anti-CCL2 antibody to enhance anti-tumour therapy

Project Description

This project investigates how the inhibition of a particular protein can be used to treat cancer. Understanding how inhibiting this protein influences cancer progression will lead to better treatment approaches for cancer.

     Using a novel anti-CCL2 antibody to enhance anti-tumour therapy

Year

2010 - 2012

Researchers

Dr Trina Stewart

Funding Body

Cancer Council Research Grant

Institution

Peter MacCallum Cancer Centre

Funding

$100,000 per annum

Updated: